Walter J. Urba

69.6k citations
223 papers · 10.7k indexed · 4 hit papers · h-index 55
Topics
Immunotherapy and Immune Responses (96 papers)Cancer Immunotherapy and Biomarkers (75 papers)CAR-T cell therapy research (62 papers)
Partner nations
United StatesChinaFrance

In The Last Decade

Walter J. Urba

221 papers receiving 10.5k citations

Hit Papers

Randomized Phase III Trial of High-Dose Interleukin-2 Ver...20042026201120182004202220162013100200300400500

Peers

Walter J. Urba
Comparison fields: 5 of 136
  • Oncology 5.9k
  • Immunology 5.5k
  • Molecular Biology 2.6k
  • Pulmonary and Respiratory Medicine 1.7k
  • Pathology and Forensic Medicine 1.1k
Replace Christian H. Ottensmeier with:
Christian H. Ottensmeier United Kingdom
Elke Jäger Germany
Taha Merghoub United States
Richard D. Carvajal United States
Célèste Lebbé France
John A. Thompson United States
Christian U. Blank Netherlands
Michael A. Bookman United States
Patrick A. Ott United States
Jonathan Cebon Australia
Walter J. Urba relative to Christian H. Ottensmeier United Kingdom Christian H. Ottensmeier's profile →
Citations per field
00.5×1.6×
Christian H. Ottensmeier · 1×
Citations per year

Countries citing papers authored by Walter J. Urba

Since Specialization
Citations

This map shows the geographic impact of Walter J. Urba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Walter J. Urba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Walter J. Urba more than expected).

Fields of papers citing papers by Walter J. Urba

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Walter J. Urba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Walter J. Urba. The network helps show where Walter J. Urba may publish in the future.

Co-authorship network of co-authors of Walter J. Urba

This figure shows the co-authorship network connecting the top 25 collaborators of Walter J. Urba. A scholar is included among the top collaborators of Walter J. Urba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Walter J. Urba. Walter J. Urba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 2
3 49
4 114
5 120
6 68
7 234
8
Results from an Integrated Safety Analysis of Urelumab, an Agonist Anti-CD137 Monoclonal Antibodybreakdown →
281
9 39
10 115
11 246
12 24
13 4
14 21
15 56
16 17
17 15
18 315
19 87
20
Polyinosinic-polycytidylic acid complexed with poly-L-lysine and carboxymethylcellulose in combination with interleukin 2 in patients with cancer: clinical and immunological effects.
45

About Walter J. Urba

Walter J. Urba is a scholar working on Immunology, Oncology and Biotechnology, having authored 223 papers that have together received 10.7k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (96 papers), Cancer Immunotherapy and Biomarkers (75 papers) and CAR-T cell therapy research (62 papers). The work is most often cited by research in Immunology (5.5k citations), Oncology (5.9k citations) and Pathology and Forensic Medicine (1.1k citations). Walter J. Urba has collaborated with scholars based in United States, China and France. Frequent co-authors include Bernard A. Fox, Hong‐Ming Hu, Dan L. Longo, John W. Smith, Brendan D. Curti, Steven O’Day, Ronald G. Steis, Omid Hamid, Jeffrey W. Clark and Andrew D. Weinberg. Their work appears in journals such as New England Journal of Medicine, Nature Communications and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026